DiscoverWIN 2017Genomic analysis of childhood tumours; biological and therapeutic implications
Genomic analysis of childhood tumours; biological and therapeutic implications

Genomic analysis of childhood tumours; biological and therapeutic implications

Update: 2017-07-31
Share

Description

Dr Lichter speaks with ecancer at WIN 2017 about germline mutations and heritable predispositions behind in paediatric brain cancer.

He outlines the Sonic Hedgehog family of genes as common driver in medulloblastoma, and discusses how translocation of genes to enhancer regions can trigger disease onset.

Dr Lichter notes that guidelines for treatments must reflect mutational subtypes, with patients whose tumours show enhanced activation of Wnt-Catenin signalling among the best prognosis compared to APC and Sonic subtypes.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Genomic analysis of childhood tumours; biological and therapeutic implications

Genomic analysis of childhood tumours; biological and therapeutic implications

Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany